13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market
13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
  1. Home
  2. Insider Trading
  3. VANLENT ANNE

VANLENT ANNE

CIK: 0001229243
Director
Primary company: PENWEST PHARMACEUTICALS CO (PPCO)

VANLENT ANNE is a corporate insider at PENWEST PHARMACEUTICALS CO (PPCO) filing SEC Form 4 transactions. 148 transactions across 11 companies, totaling $301,111 in purchases and $257,246 in sales. Source: SEC EDGAR.

Total Transactions
148
Total Buy Value
$301K
Total Sell Value
$257K
Net Activity
+$44K
Last Transaction
Jun 2025
Companies
11

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Company
Type
Shares
Price
Value
Shares After
Date
SEC
Trevi Therapeutics, Inc.
TRVI
Award45,000--45,000
6/11/2025
Filed: 6/13/2025
Filing →
Trevi Therapeutics, Inc.
TRVI
Award30,000--30,000
6/13/2024
Filed: 6/14/2024
Filing →
Trevi Therapeutics, Inc.
TRVI
Award30,000$0.00$030,000
6/28/2023
Filed: 6/30/2023
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition14,000--0
11/30/2022
Filed: 12/1/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition12,000--0
11/30/2022
Filed: 12/1/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition10,000--0
11/30/2022
Filed: 12/1/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition10,000--0
11/30/2022
Filed: 12/1/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition10,000--0
11/30/2022
Filed: 12/1/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition8,000--0
11/30/2022
Filed: 12/1/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Disposition16,000--0
11/30/2022
Filed: 12/1/2022
Filing →
Trevi Therapeutics, Inc.
TRVI
Award20,000$0.00$020,000
6/23/2022
Filed: 7/1/2022
Filing →
Trevi Therapeutics, Inc.
TRVI
Award20,000$0.00$020,000
6/23/2022
Filed: 6/23/2022
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Award14,000$0.00$014,000
11/30/2021
Filed: 12/2/2021
Filing →
Trevi Therapeutics, Inc.
TRVI
Award20,000$0.00$020,000
6/16/2021
Filed: 6/17/2021
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Award12,000$0.00$012,000
12/16/2020
Filed: 12/18/2020
Filing →
Trevi Therapeutics, Inc.
TRVI
Award14,210$0.00$014,210
6/11/2020
Filed: 6/15/2020
Filing →
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Award10,000$0.00$010,000
12/4/2019
Filed: 12/6/2019
Filing →
Vaxart, Inc.
VXRT
Award12,700$0.00$012,700
6/12/2019
Filed: 6/14/2019
Filing →
Vaxart, Inc.
VXRT
Award9,000$0.00$09,000
6/12/2019
Filed: 6/14/2019
Filing →
Trevi Therapeutics, Inc.
TRVI
Conversion47,807$0.00$00
5/9/2019
Filed: 5/13/2019
Filing →
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
45,000
Price
-
Value
-
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
30,000
Price
-
Value
-
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
30,000
Price
$0.00
Value
$0
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
14,000
Price
-
Value
-
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
12,000
Price
-
Value
-
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
10,000
Price
-
Value
-
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
10,000
Price
-
Value
-
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
10,000
Price
-
Value
-
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
8,000
Price
-
Value
-
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Disposition
Shares
16,000
Price
-
Value
-
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
20,000
Price
$0.00
Value
$0
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Award
Shares
14,000
Price
$0.00
Value
$0
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
20,000
Price
$0.00
Value
$0
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Award
Shares
12,000
Price
$0.00
Value
$0
Trevi Therapeutics, Inc.
TRVI
Type
Award
Shares
14,210
Price
$0.00
Value
$0
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
Type
Award
Shares
10,000
Price
$0.00
Value
$0
Vaxart, Inc.
VXRT
Type
Award
Shares
12,700
Price
$0.00
Value
$0
Vaxart, Inc.
VXRT
Type
Award
Shares
9,000
Price
$0.00
Value
$0
Trevi Therapeutics, Inc.
TRVI
Type
Conversion
Shares
47,807
Price
$0.00
Value
$0
...
AI Agent

Try asking...

FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market